Carcinoma in situ of unspecified female genital organs refers to a localized cancerous condition where abnormal cells are present but have not invaded surrounding tissues. This condition is clinically significant as it may progress to invasive cancer if left untreated. The ICD-10 Code D07.30 facilitates accurate diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively track and manage cases of this condition.
ICD-10 Code D07.30 represents carcinoma in situ of unspecified female genital organs, indicating the presence of abnormal cells that have not yet invaded surrounding tissues. This code is used in clinical documentation and billing when diagnosing patients with this condition, ensuring proper tracking and management of potential progression to invasive cancer.
Carcinoma in situ of unspecified female genital organs is characterized by the presence of malignant cells confined to the epithelial layer of the genital organs without invasion into deeper tissues. This condition requires medical attention due to its potential to progress to invasive cancer if not treated appropriately.
ICD-10 Code D07.30 is utilized in SOAP notes to document the diagnosis of carcinoma in situ of unspecified female genital organs. It plays a crucial role in capturing patient symptoms, assessment findings, and treatment plans, relevant in both acute and chronic care settings.
In SOAP notes, ICD-10 Code D07.30 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of carcinoma in situ of unspecified female genital organs. This ensures continuity of care, supports accurate billing, and meets EHR documentation standards.
The management of carcinoma in situ of unspecified female genital organs may require hospitalization for further evaluation and treatment. Treatment options focus on preventing progression to invasive cancer.


HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.
Learn moreICD-10 Code D07.30 is essential for accurate billing in hospital, ER, or outpatient settings, ensuring proper reimbursement for services rendered.
| CPT Code | Description |
|---|---|
| 88141 | Cytopathology, cervical or vaginal, collected in preservative fluid, automated thin layer preparation. |
| 57460 | Colposcopy of the cervix including biopsy, if performed. |
| 88305 | Pathology examination, surgical, gross and microscopic examination. |
Common Questions About Using ICD-10 Code D07.30 for Carcinoma in situ of unspecified female genital organs
What are the common symptoms of carcinoma in situ of unspecified female genital organs?
Carcinoma in situ often presents asymptomatically, but may include abnormal vaginal bleeding or discharge. Regular screenings are crucial for early detection.
How is carcinoma in situ treated?
Treatment may involve surgical intervention, such as excision or laser therapy, depending on the extent of the condition. Regular follow-up is essential.
Is carcinoma in situ considered cancer?
Yes, carcinoma in situ is classified as a type of cancer, as it involves abnormal cells that have the potential to become invasive if not treated.
How often should patients be screened for carcinoma in situ?
Patients with risk factors should undergo regular screenings as recommended by their healthcare provider, typically every 1-3 years depending on individual risk.
Clinical Notes
SOAP notes
DAP notes
AI medical notes